Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JE-CV vs SA14-14-2 in Thai Infants
NCT01092507Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2010
- Primary completion
- Sep 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of japanese encephalitis chimeric virus vaccine in Japanese encephalitis (JE), sponsored by Sanofi. Started Mar 2010; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01092507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092507.